Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib ointment in mild to moderate atopic dermatitis
NCT02001181Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing Tofacitinib Ointment with Vehicle Ointment (2 arms). Primary endpoint: Percent Change From Baseline in Eczema Area and Severity Index Total Score at 4 weeks. Started Dec 2013; status: completed.
02
Drugs
INN-04-01
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02001181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001181.